Dr. Matthew L. Ortman, MD

Dr. Ortman practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Ortman's NPI, 1366582116, was assigned on February 8, 2007. Dr. Ortman graduated from University of Maryland School of Medicine in 2003. Dr. Ortman holds New Jersey license 25MA08236100.

Dr. Ortman's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Ortman's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Ortman is also affiliated with Inspira Medical Center Elmer. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Ortman to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortman practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ortman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Ortman's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 4,222 Medicare services from Dr. Ortman across 32 procedure codes in 2024, for 976 Medicare patients. Medicare paid $246,304 for them.

CMS counts 976 Medicare patients who saw Dr. Ortman in 2024. The largest group is 65 to 74, with 378 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ortman's median patient age at 70, with 42% women.

In 2024, Dr. Ortman wrote 876 Medicare Part D claims for 268 patients. 73% of them were for generic drugs. CMS names the drug for 750 of them, across 20 drugs with 11 or more claims each, at $200,148 in total drug cost. In 2023, CMS named 738 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Ortman for performance year 2024, reported as part of a group. Dr. Ortman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of pacemaker insertion or repair by Dr. Ortman, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Ortman, published from 2010 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Arrhythmias, Cardiac, Cardiomyopathies and Sarcoidosis. Dr. Ortman has published most often in Heart Rhythm. Dr. Ortman's most frequent co-authors are Frank M. Bogun, MD, Lynda E. Rosenfeld, MD and John Andriulli, DO.

CMS Open Payments shows 514 general payments to Dr. Ortman from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Abbott Laboratories paid the most, $3,479.

Dr. Ortman graduated from University of Maryland School of Medicine in 2003.